Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2005
12/29/2005US20050287135 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/29/2005US20050287134 use of a first drug operative to produce local capillary vasodilatation and/or augmented rate of bulk flow which is mixed with a fluid, then delivered subcutaneously or into deeper tissues by use of a hyperdermic needle or infiltration cannula
12/29/2005US20050287124 Method for inducing bone marrow-derived cells in injured epithelial site and a method for repairing injured epithelium
12/29/2005US20050284812 Process for preparing water soluble diterpenes and their applications
12/29/2005CA2575101A1 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use
12/29/2005CA2570389A1 Treatments comprising strontium for rheumatic and arthritic diseases and pain
12/29/2005CA2570386A1 Methods of using albuterol and calcium activated potassium channel openers
12/29/2005CA2570184A1 Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent
12/29/2005CA2569468A1 Ophthalmic formulations including selective alpha 1 antagonists
12/29/2005CA2569310A1 Pharmaceutical compositions
12/29/2005CA2569116A1 Gram-positive carbapenem antibacterials and processes for their preparation
12/29/2005CA2569112A1 Carbapenem antibacterials with gram-negative activity and processes for their preparation
12/29/2005CA2565972A1 Ex-vivo application of solid microparticulate therapeutic agents
12/29/2005CA2564791A1 High pressure spray-dry of bioactive materials
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609494A1 Heparin barrier coating for controlled drug release
12/28/2005EP1609480A1 Remedy for spinal canal stenosis
12/28/2005EP1609479A1 Tumorigenesis inhibitor
12/28/2005EP1609477A1 Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
12/28/2005EP1609470A1 Nasal delivery of apomorphine
12/28/2005EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
12/28/2005EP1609362A2 Non-systemic control of parasites
12/28/2005EP1608407A2 Dispersible formulation of an anti-inflammatory agent
12/28/2005EP1608406A1 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
12/28/2005EP1608405A2 Nitric oxide in treatment of inflammation
12/28/2005EP1608391A2 Composition for inducing of immunotolerance
12/28/2005EP1608385A2 Therapeutic compositions
12/28/2005EP1608377A2 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608356A2 Compositions for treating microbial and parasitic infections in cattle and other animals
12/28/2005EP1608354A1 Compounds having serotonin 5-ht7 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
12/28/2005EP1608349A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
12/28/2005EP1608341A1 Water-soluble tablets of metformin
12/28/2005EP1608311A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
12/28/2005EP1531831B1 Fosinopril formulation
12/28/2005EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
12/28/2005EP1432450B1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/28/2005EP1427403B1 Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation
12/28/2005EP1385512B1 Use of pyridoindolone derivatives for preparing anticancer medicines
12/28/2005EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
12/28/2005EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function
12/28/2005EP1263746B1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments
12/28/2005EP1257276B1 Antiviral azaindole derivatives
12/28/2005EP1251843B1 Compositions for delivery of a cortisol antagonist
12/28/2005EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1218023B1 Method for calming human beings using personal care compositions
12/28/2005EP1182931B1 Stable biocidal compositions
12/28/2005EP1073683B1 G-csf receptor agonist antibodies and screening method therefor
12/28/2005EP1025227B1 Human toll homologues
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005CN1714571A Circuit for processing video signal containing information such as closed caption
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714148A Viral deconstruction through capsid assembly in vitro
12/28/2005CN1714089A Novel use of substituted aminomethyl chromans
12/28/2005CN1713926A Peritoneal dialysis method
12/28/2005CN1713922A Combinations of (a) an ATP-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents
12/28/2005CN1713918A Muscle building preparation
12/28/2005CN1713915A Methods for preventing and treating bone loss with steroid compounds
12/28/2005CN1713910A Azaindole derivatives as inhibitors of p38 kinase
12/28/2005CN1713900A Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
12/28/2005CN1713888A Cream for treatment of skin injured by the sun
12/28/2005CN1712069A Dietotherapeutic electuary
12/28/2005CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/28/2005CN1233324C Use of composition of intraocular pressure reducing agent
12/28/2005CN1233257C A composition containing carvacrol and thymol for use as abactericide
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979675 Treatment of cancer with 2-deoxyglucose
12/27/2005US6979532 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
12/27/2005US6979471 plant extracts from Glycyrrhiza glabra; glycyrrhizin; bio-enhancers and bioavailability facilitators for anti-infectives, anti-cancer agents; non-toxic
12/27/2005US6979463 Stable extended release oral dosage composition
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979445 Method for treating von willebrand's disease
12/27/2005US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2131911C Minimizing progestin associated breakthrough bleeding
12/22/2005WO2005122379A2 Alpha-4 beta-1 integrin ligands for imaging and therapy
12/22/2005WO2005121802A1 Protein differentiation
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121320A1 Autonomouos replication promoter for stem cells
12/22/2005WO2005120576A2 Composition and method for improving pancreatic islet cell survival
12/22/2005WO2005120575A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation
12/22/2005WO2005120574A1 Drug having regulatory cell ligand contained in liposome
12/22/2005WO2005120539A2 Novel use of peptide compounds for treating pain in trigeminal neuralgia
12/22/2005WO2005120524A2 Nutritional formulations
12/22/2005WO2005120523A1 Methods and compositions for treating mood disorder
12/22/2005WO2005120514A1 Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
12/22/2005WO2005120480A1 Antitumor effect fortifier, antitumor agent and method of therapy for cancer
12/22/2005WO2005120476A2 Novel use of peptide compounds for treating amyotrophic lateral sclerosis
12/22/2005WO2005120475A2 Pharmaceutical composition for the treatment of bacterial infections and sepsis
12/22/2005WO2005120455A1 Soluble strip for oral or topical administration
12/22/2005WO2005120432A1 Dispenser for progestin used for acute and maintenance treatment of dub
12/22/2005WO2005120407A2 Preparation for localized delivery of therapeutic agent
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 1151